GBTsol™ Immune Cell Analyzer

Revolutionizing Immunocyte Diagnostics with Microfiltration Technology

GBTsol™ICA is an innovative in vitro diagnostic device designed to revolutionize white blood cell analysis through advanced microfiltration technology. Engineered by GBTSol, this compact and efficient platform enables precise immunocyte diagnostics by separating white blood cells and analyzing infectious disease markers with unparalleled speed and accuracy.

By leveraging proprietary microfiltration technology—GBT’s core innovation—GBTsol™ICA isolates white blood cells from a small blood sample and detects CD markers associated with infectious diseases. This method delivers more accurate and faster results compared to traditional techniques like flow cytometry, making it ideal for clinical and point-of-care settings.

Key Features

• Advanced Leukocyte Separation: Selectively isolates white blood cells from whole blood using proprietary microfiltration membranes.
• High-Precision CD Marker Detection: Uses fluorescence-based reactions to count white blood cells and monitor CD markers with superior accuracy.
• Minimal Sample Requirement: Requires only 5μL of blood, significantly reducing patient discomfort.
• Fast and Efficient: Streamlines the entire diagnostic process, eliminating multiple preparation steps.
• User-Friendly: Designed for easy operation in clinical environments without the need for complex equipment or specialized training.
   

Why Choose GBTsol™ICA?

• High Accuracy: Delivers precise leukocyte counts and CD marker monitoring for infectious diseases.
• Time-Saving Workflow: Reduces diagnostic time by eliminating preprocessing steps.
• Minimal Invasiveness: Performs complete analysis with just a small blood sample.
• Ease of Use: Simplifies operation without compromising diagnostic quality.
   

Ideal For

• Hospitals and Clinics: Point-of-care testing for infectious diseases and immunological profiling.
• Laboratories: Fast, reliable analysis without the complexity of flow cytometry.
• Emergency and Mobile Units: Compact format and minimal sample requirement ideal for field diagnostics.
• Research Institutions: Accurate CD marker analysis for immunology and infectious disease studies.
   

GBTsol™ICA represents the next generation of immunocyte diagnostic platforms—empowering healthcare professionals to deliver timely, accurate, and minimally invasive diagnostics across a wide range of clinical settings.